Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Uncategorized

Reata Pharmaceuticals Q1 EPS $(1.16) Beats $(2.10) Estimate

Reata Pharmaceuticals (NASDAQ:RETA) reported quarterly losses of $(1.16) per share which beat the analyst consensus estimate of $(2.10) by 44.76 percent. This is a 21.09 percent increase over losses of $(1.47) per share
byBill Haddad
May 6, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Reata Pharmaceuticals (NASDAQ:RETA) reported quarterly losses of $(1.16) per share which beat the analyst consensus estimate of $(2.10) by 44.76 percent. This is a 21.09 percent increase over losses of $(1.47) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts